Study site | Drug used | Enrolled | Parasitaemic patients on D0 N (%) | Patients seen at D28 N (%) | Crude parasitological failure (%) | Geometric mean parasite density D28 (p/μl) | PCR adjusted failure rate* | PCR adjusted cure rate |
---|---|---|---|---|---|---|---|---|
Badeku & Ojoku/Ajia Nigeria | AL | 432 | 306 (70.8%) C.I. 67%–75% | 184 (60.1%) | 77/184 (41.8%) C.I. 35%–49% | 2835 | 14/154 (9.1%) | 90.9% C.I. 86%–95% |
Ejisu-Juaben, Ghana | AS/AQ | 848 | 603 (71.1%) C.I. 68%–74% | 205 (34%) | 57/205 (27.8%) C.I. 22%–34% | 15080 | 17/197 (8.6%) | 91.4% C.I. 87%–95% |
Bugiri, Uganda | AL | 460 | 280 (60.9%) C.I. 56%–65% | 217 (77.5%) | 8/217 (3.7%) C.I. 1.2%–6.2% | N/A | 6/216 (2.8%) | 97.2% C.I. 95%–99% |